Sort
48,018 grants matching “immunotherapy”
Targeting Effector Immune cells to Cancer with Chemically Self-Assembled Nanorings (CSANs)
$559,057Carston R. Wagner · University Of Minnesota · R01 · FY2022 · CA
Clinical Trials to Evaluate the Safety and Antiviral Effects of High Affinity Gag
$559,030Carl H. June · University Of Pennsylvania · U19 · FY2009 · AI
Stanford Molecular Imaging Scholars (SMIS) Program
$559,021Craig S Levin · Stanford University · T32 · FY2023 · CA
Immunotherapeutic Modulation of Peanut Allergy
$559,014Scott H Sicherer · Icahn School Of Medicine At Mount Sinai · U19 · FY2008 · AI
PILOT STUDY OF ANTI-CD40L MAB IN REPEAT CADAVER DONOR TRANSPLANTS
$558,973New York Medical College · U01 · FY2000 · AI
Engineered Nano-formulations for STING Activation
$558,881James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2024 · DE
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
$558,828Elinor Karlsson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · CA
Genetic Control of the SYK Tyrosine-protein Kinase in Allergy
$558,733Li Gao · Johns Hopkins University · R01 · FY2025 · AI
PAG is a novel target in immunotherapy
$558,683Adam Mor · Columbia University Health Sciences · R01 · FY2021 · AI
Regulation of the intestinal stem cell compartment after hematopoietic transplantation
$558,680Alan M Hanash · Sloan-Kettering Inst Can Research · R01 · FY2018 · HL
Regulation of the intestinal stem cell compartment after hematopoietic transplantation
$558,680Alan M Hanash · Sloan-Kettering Inst Can Research · R01 · FY2016 · HL
Regulation of the intestinal stem cell compartment after hematopoietic transplantation
$558,680Alan M Hanash · Sloan-Kettering Inst Can Research · R01 · FY2015 · HL
Regulation of the intestinal stem cell compartment after hematopoietic transplantation
$558,680Alan M Hanash · Sloan-Kettering Inst Can Research · R01 · FY2017 · HL
Novel Approaches Targeting B7-H3 in Castration-resistant Prostate Cancer
$558,663Di Zhao · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Elucidating genetics of response to immune checkpoint blockade in lung cancer
$558,644Naiyer A Rizvi · Columbia University Health Sciences · R01 · FY2018 · CA
Elucidating genetics of response to immune checkpoint blockade in lung cancer
$558,644Naiyer A Rizvi · Columbia University Health Sciences · R01 · FY2020 · CA
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors
$558,602Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA
Manipulating normal estrogen physiology as a therapeutic approach in cancer
$558,602Donald P McDonnell · Duke University · R01 · FY2023 · CA
Developing potent HIV-specific CAR T cells through optimizing antigen sensitivity
$558,595Daniel Thomas Claiborne · Wistar Institute · R01 · FY2025 · AI
Developing potent HIV-specific CAR T cells through optimizing antigen sensitivity
$558,595Daniel Thomas Claiborne · Wistar Institute · R01 · FY2024 · AI
Dissecting Molecular Mechanisms of Tumor-Induced Myeloid-Mediated Immune Suppression in Triple-Negative Breast Cancer
$558,523Jianmin Zhang · University Of Toledo Health Sci Campus · R01 · FY2025 · CA
Methamphetamine and HIV: Defective immunity with CD8 T cell dysfunction
$558,479Howard S. Fox · University Of Nebraska Medical Center · R01 · FY2012 · DA
Targeting Aldehyde Dehydrogenase for Cancer Prevention
$558,440Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2024 · CA
MYELOID-DERIVED SUPPRESSOR CELLS EXPRESSING MYELOPEROXIDASE DIRECTLY INHIBIT ADAPTIVE IMMUNE CELLS LIMITING IMMUNOTHERAPY IN MELANOMA
$558,390West Virginia University Research Corporation · · FY2019 · Defense Health Agency
MECHANISMS OF CHRONIC HEPATITIS B INFECTION
$558,374Vaccine Research Institute Of San Diego · R01 · FY2001 · AI